Inventor · disambiguated record
Michael S. C. Fung
Also filed as: FUNG MICHAEL · FUNG MICHAEL S C
28 granted patents·5 pending applications·799 citations·filing 1991–2016
98Inventor score
Top patents by PatentIndex Score
33 records- 0198US7112327B2Inhibition of complement activationTANOX INC·Filed 2005·Granted Sep 26, 2006·56 cites·22 claims
- 0297US6956107B2Inhibitors of complement activationTANOX INC·Filed 2001·Granted Oct 18, 2005·110 cites·9 claims
- 0396US7432356B2Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5bGENENTECH INC·Filed 2002·Granted Oct 7, 2008·82 cites·12 claims
- 0496US6534058B2Anti-C5 monoclonal antibodiesTANOX INC·Filed 2001·Granted Mar 18, 2003·94 cites·8 claims
- 0595US8372404B2Anti-C5/C5a antibodies and methods of useGENENTECH INC·Filed 2012·Granted Feb 12, 2013·27 cites·15 claims
- 0695US8124090B2Anti-factor D antibodies and methods of treatmentFUNG MICHAEL S C·Filed 2011·Granted Feb 28, 2012·24 cites·50 claims
- 0795US7943135B2Method of treatment using anti-factor D antibodiesGENENTECH INC·Filed 2006·Granted May 17, 2011·27 cites·11 claims
- 0895US7439331B2Inhibition of complement activationGENENTECH INC·Filed 2006·Granted Oct 21, 2008·43 cites·6 claims
- 0994US8221756B2Complement inhibitors and uses thereofFUNG MICHAEL S C·Filed 2011·Granted Jul 17, 2012·24 cites·12 claims
- 1094US6998468B2Anti-C2/C2a inhibitors of complement activationTANOX INC·Filed 2001·Granted Feb 14, 2006·46 cites·12 claims
- 1193US8383802B2Nucleic acids encoding antibodies that bind factor DGENENTECH INC·Filed 2012·Granted Feb 26, 2013·12 cites·8 claims
- 1293US8236317B2Methods of treating with anti-factor D antibodiesFUNG MICHAEL S C·Filed 2012·Granted Aug 7, 2012·15 cites·16 claims
- 1393US8206716B2Methods of treating with anti-C5/C5a specific antibodiesFUNG MICHAEL·Filed 2008·Granted Jun 26, 2012·30 cites·22 claims
- 1490US7927592B2Method of inhibiting complement activationGENENTECH INC·Filed 2005·Granted Apr 19, 2011·11 cites·15 claims
- 1589US8765131B2Methods of inhibiting alternative pathway complement activation with anti-factor D antibodiesGENENTECH INC·Filed 2013·Granted Jul 1, 2014·7 cites·31 claims
- 1686US8907072B2Nucleic acids encoding antibody 137-26 which binds C5 and C5aGENENTECH INC·Filed 2013·Granted Dec 9, 2014·6 cites·10 claims
- 1783US5245015AMonoclonal antibodies which neutralize HIV-1 through reaction with a conformational epitope in vitroTANOX BIOSYSTEMS INC·Filed 1991·Granted Sep 14, 1993·53 cites·3 claims
- 1880US8911735B2Complement inhibitors and uses thereofFUNG MICHAEL S C·Filed 2012·Granted Dec 16, 2014·3 cites·8 claims
- 1976US5854400AMonoclonal antibodies which neutralize HIV-1 infectionTANOX INC·Filed 1992·Granted Dec 29, 1998·36 cites·10 claims
- 2068US5266478AAntibodies which target a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120TANOX BIOSYSTEMS INC·Filed 1991·Granted Nov 30, 1993·24 cites·4 claims
- 2166US2015010569A1Inhibitors Of Complement ActivationGENENTECH INC·Filed 2014·Application pending·0 cites
- 2265US5981278AChimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDSTANOX INC·Filed 1991·Granted Nov 9, 1999·20 cites·6 claims
- 2365US2015086572A1Complement Pathway Inhibitors Binding To C5 And C5A Without Preventing The Formation Of C5BGENENTECH INC·Filed 2014·Application pending·0 cites
- 2462US6309880B1Antibodies specific for CD4-binding domain of HIV-1TANOX INC·Filed 1993·Granted Oct 30, 2001·18 cites·4 claims
- 2561US5728814AGC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodiesTANOX BIOSYSTEMS INC·Filed 1996·Granted Mar 17, 1998·7 cites·2 claims
- 2661US2016264682A1Inhibitors Of Complement ActivationGENENTECH INC·Filed 2016·Application pending·0 cites
- 2758US2016200805A1Complement Pathway Inhibitors Binding To C5 And C5a Without Preventing The Formation Of C5bGENENTECH INC·Filed 2016·Application pending·0 cites
- 2856US5739306AgC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodiesTANOX BIOSYSTEMS INC·Filed 1996·Granted Apr 14, 1998·12 cites·2 claims
- 2947US6657050B1Chimeric viral-neutralizing immunoglobulinsTANOX INC·Filed 1993·Granted Dec 2, 2003·11 cites·3 claims
- 3042US2004198961A1Fce fusion proteins for treatment of allergy and asthmaFiled 2002·Application pending·0 cites
- 3135US5731428AgC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodiesTANUX BIOSYSTEMS INC·Filed 1996·Granted Mar 24, 1998·1 cites·2 claims
- 3232US5691447AGC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodiesTANOX BIOSYSTEMS INC·Filed 1995·Granted Nov 25, 1997·0 cites·3 claims
- 3332US5652333AgC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodiesTANOX BIOSYSTEMS INC·Filed 1996·Granted Jul 29, 1997·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Michael S. C. Fung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →